FXYD2 mRNA expression represents a new independent factor that affects survival of glioma patients and predicts chemosensitivity of patients to temozolomide

PURPOSE: Glioma is the most common primary intracranial tumor. Owing to the poor prognosis associated with high-grade gliomas, there is an urgent need to identify biomarkers related to prognosis and treatment sensitivity. Here, we analyze the expression of FXYD2 mRNA in gliomas, and explore its clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Kaijia, Jiang, Tao, Liu, Yanwei, Zhao, Zheng, Huang, Lijie, Li, Guanzhang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576926/
https://www.ncbi.nlm.nih.gov/pubmed/34753441
http://dx.doi.org/10.1186/s12883-021-02476-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576926/
https://www.ncbi.nlm.nih.gov/pubmed/34753441
http://dx.doi.org/10.1186/s12883-021-02476-2

Ejemplares similares